The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Open accessAbstract
Tumor cells exhibit unique metabolic adaptations that are increasingly viewed as potential targets for novel and specific cancer therapies. Among these targets, the carnitine palmitoyltransferase system is responsible for delivering the long-chain fatty acid (FA) from cytoplasm into mitochondria for oxidation, where carnitine palmitoyltransferase I (CPTI) catalyzes the rate-limiting step of fatty acid oxidation (FAO). With increasing understanding of the crucial role had by fatty acid oxidation in cancer, CPTI has received renewed attention as a pivotal mediator in cancer metabolic mechanism. CPTI activates FAO and fuels cancer growth via ATP and NADPH production, constituting an essential part of cancer metabolism adaptation. Moreover, CPTI also functionally intertwines with other key pathways and factors to regulate gene expression and apoptosis of cancer cell. Here, we summarize recent findings and update the current understanding of FAO and CPTI in cancer and provide theoretical basis for this enzyme as an emerging potential molecular target in cancer therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Ambros, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00616-x · Cited by 1,697
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616
Santos, C. R., & Schulze, A. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08644.x · Cited by 1,335
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903
Monti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.
McGarry, J. D., Mannaerts, G. P., & Foster, D. W. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108764 · Cited by 736
Fatty acid metabolism: Target for metabolic syndrome
Wakil, S. J., & Abu-Elheiga, L. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800079-jlr200 · Cited by 731
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Bensaad, K., Favaro, E., Lewis, C. A., Peck, B., Lord, S., Collins, J. M., Pinnick, K. E., Wigfield, S., Buffa, F. M., Li, J.-L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.056 · Cited by 665
Fatty acid carbon is essential for dNTP synthesis in endothelial cells
Schoors, S., Bruning, U., Missiaen, R., Queiroz, K. C. S., Borgers, G., Elia, I., Zecchin, A., Cantelmo, A. R., Christen, S., Goveia, J., et al. (2015) · Nature · doi:10.1038/nature14362 · Cited by 646
The NAD metabolome — a key determinant of cancer cell biology
Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3340 · Cited by 639
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects
BONNEFONT, J. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.004 · Cited by 637
Hossain, F., Al-Khami, A. A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0036 · Cited by 588
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545
The Role of Prolactin in Mammary Carcinoma
Clevenger, C. V., Furth, P. A., Hankinson, S. E., & Schuler, L. A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0036 · Cited by 545
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K., Tondera, D., Gounarides, J., Yin, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 528
Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., Huang, P., Sawyer, S. K., Fuerth, B., Faubert, B., et al. (2011) · Genes & Development · doi:10.1101/gad.1987211 · Cited by 490
Chain length-specific properties of ceramides
Grösch, S., Schiffmann, S., & Geisslinger, G. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.001 · Cited by 483
Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids
Zaidi, N., Lupien, L., Kuemmerle, N. B., Kinlaw, W. B., Swinnen, J. V., & Smans, K. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.08.005 · Cited by 477
Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., & Wu, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 469
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome
Watkins, P. A., Maiguel, D., Jia, Z., & Pevsner, J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700378-jlr200 · Cited by 377
Huang, D., Li, T., Li, X., Zhang, L., Sun, L., He, X., Zhong, X., Jia, D., Song, L., Semenza, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.028 · Cited by 352
New aspects of the Warburg effect in cancer cell biology
Bensinger, S. J., & Christofk, H. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.003 · Cited by 307
Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
Schlaepfer, I. R., Rider, L., Rodrigues, L. U., Gijón, M. A., Pac, C. T., Romero, L., Cimic, A., Sirintrapun, S. J., Glodé, L. M., Eckel, R. H., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0183 · Cited by 304
MicroRNA-370 controls the expression of MicroRNA-122 and Cpt1α and affects lipid metabolism
Iliopoulos, D., Drosatos, K., Hiyama, Y., Goldberg, I. J., & Zannis, V. I. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004812 · Cited by 300
Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome
Schreurs, M., Kuipers, F., & Van Der Leij, F. R. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00642.x · Cited by 296
The fat side of prostate cancer
Zadra, G., Photopoulos, C., & Loda, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.010 · Cited by 291
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Büll, U., & Jakse, G. (1996) · PubMed · Cited by 289
MicroRNA-34a: a potential therapeutic target in human cancer
Li, X. J., Ren, Z. J., & Tang, J. H. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.270 · Cited by 287
Lopaschuk, G. D., Wall, S. R., Olley, P. M., & Davies, N. J. (1988) · Circulation Research · doi:10.1161/01.res.63.6.1036 · Cited by 284
Gatza, M. L., Silva, G. O., Parker, J. S., Fan, C., & Perou, C. M. (2014) · Nature Genetics · doi:10.1038/ng.3073 · Cited by 258
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Bull, U., & Jakse, G. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66366-3 · Cited by 240
Ricciardi, M. R., Mirabilii, S., Allegretti, M., Licchetta, R., Calarco, A., Torrisi, M. R., Foà, R., Nicolai, R., Peluso, G., & Tafuri, A. (2015) · Blood · doi:10.1182/blood-2014-12-617498 · Cited by 222
Yan, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i12.3492 · Cited by 219
Sierra, A. Y., Gratacós, E., Carrasco, P., Clotet, J., Ureña, J., Serra, D., Asins, G., Hegardt, F. G., & Casals, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707965200 · Cited by 190
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death
Lee, E. A., Angka, L., Rota, S.-G., Hanlon, T., Mitchell, A., Hurren, R., Wang, X. M., Gronda, M., Boyaci, E., Bojko, B., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2676 · Cited by 179
PAX3–FOXO1 fusion gene in rhabdomyosarcoma
Linardic, C. M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.035 · Cited by 175
Ashrafian, H., Horowitz, J. D., & Frenneaux, M. P. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00006.x · Cited by 173
Peroxisomal branched chain fatty acid ?-oxidation pathway is upregulated in prostate cancer
Zha, S., Ferdinandusse, S., Hicks, J. L., Denis, S., Dunn, T. A., Wanders, R. J., Luo, J., De Marzo, A. M., & Isaacs, W. B. (2005) · The Prostate · doi:10.1002/pros.20177 · Cited by 164
Carnitine palmitoyltransferase 1C: From cognition to cancer
Casals, N., Zammit, V. A., Herrero, L., Fadó, R., Rodríguez‐Rodríguez, R., & Serra, D. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.11.004 · Cited by 154
Al-Khami, A. A., Hossain, F. M., Wyczechowska, D. D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o18 · Cited by 150
Shao, H., Mohamed, E. M., Xu, G.-Y. G., Waters, M., Jing, K., Ma, Y., Zhang, Y., Spiegel, S., Idowu, M., & Fang, X.-J. (2015) · OncoTarget · doi:10.18632/oncotarget.6757 · Cited by 119
Patella, F., Schug, Z. T., Persi, E., Neilson, L. J., Erami, Z., Avanzato, D., Maione, F., Hernandez-Fernaud, J. R., Mackay, G., Zheng, L., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.045575 · Cited by 118
Lin (2010) · International Journal of Oncology · doi:10.3892/ijo_00000686 · Cited by 117
Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
Tirado-Vélez, J. M., Joumady, I., Sáez-Benito, A., Cózar‐Castellano, I., & Perdomo, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046484 · Cited by 115
Pacilli, A., Calienni, M., Margarucci, S., D’Apolito, M., Petillo, O., Rocchi, L., Pasquinelli, G., Nicolai, R., Koverech, A., Calvani, M., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt030 · Cited by 114
Schlaepfer, I. R., Nambiar, D. K., Ramteke, A. S., Kumar, R., Dhar, D., Agarwal, C., Bergman, B. C., Graner, M. W., MARONI, P. D., Singh, R. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4479 · Cited by 112
High Metastaticgastric and Breast Cancer Cells Consume Oleic Acid in an AMPK Dependent Manner
Li, S., Zhou, T., Li, C., Dai, Z., Che, D., Yao, Y., Li, L., Ma, J., Yang, X., & Gao, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097330 · Cited by 110
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia
Tung, S., Shi, Y., Wong, K., Zhu, F., Gorczynski, R., Laister, R. C., Minden, M. D., Blechert, A.-K., Genzel, Y., Reichl, U., et al. (2013) · Blood · doi:10.1182/blood-2013-03-489468 · Cited by 100
Conti, R., Mannucci, E., Pessotto, P., Tassoni, E., Carminati, P., Giannessi, F., & Arduini, A. (2011) · Diabetes · doi:10.2337/db10-0346 · Cited by 98
Sanchez-Macedo, N., Feng, J., Faubert, B., Chang, N., Elia, A., Rushing, E. J., Tsuchihara, K., Bungard, D., Berger, S. L., Jones, R. G., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.168 · Cited by 98
Structural insight into function and regulation of carnitine palmitoyltransferase
Rufer, A. C., Thoma, R., & Hennig, M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0035-1 · Cited by 98
Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer
Pucci, S., Zonetti, M. J., Fisco, T., Polidoro, C., Bocchinfuso, G., Palleschi, A., Novelli, G., Spagnoli, L. G., & Mazzarelli, P. (2016) · Oncotarget · doi:10.18632/oncotarget.6964 · Cited by 96
Namgaladze, D., Lips, S., Leiker, T. J., Murphy, R. C., Ekroos, K., Ferreirós, N., Geißlinger, G., & Brüne, B. (2014) · Diabetologia · doi:10.1007/s00125-014-3173-4 · Cited by 94
Wolfgang, M. J., Cha, S. H., Millington, D. S., Cline, G. W., Shulman, G. I., Suwa, A., Asaumi, M., Kurama, T., Shimokawa, T., & Lane, M. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05255.x · Cited by 93
Targeting fatty acid metabolism in cancer and endothelial cells
Harjes, U., Kalucka, J. M., & Carmeliet, P. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.011 · Cited by 87
Wolfgang, M. J., & Lane, M. D. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092532 · Cited by 85
Ratheiser, K. M., Schneeweiss, B., Waldhäusl, W., Fasching, P., Korn, A., Nowotny, P., Rohac, M., & Wolf, H. (1991) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(91)90214-h · Cited by 82
Calhabeu, F., Hayashi, S., Morgan, J. E., Relaix, F., & Zammit, P. S. (2012) · Oncogene · doi:10.1038/onc.2012.73 · Cited by 77
Giannessi, F., Pessotto, P., Tassoni, E., Chiodi, P., Conti, R., de Angelis, F., Dell'uomo, N., Catini, R., Deias, R., Tinti, M., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020979u · Cited by 77
Linher‐Melville, K., Zantinge, S., Sanli, T., Gerstein, H. C., Tsakiridis, T. K., & Singh, G. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-56 · Cited by 75
Merrill, C. L. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.93 · Cited by 75
Schlaepfer, I. R., Glodé, L. M., Hitz, C. A., Pac, C. T., Boyle, K. E., MARONI, P. D., Deep, G., Agarwal, R., Lucia, S. M., Cramer, S. D., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0814-4 · Cited by 74
Rodríguez‐Enríquez, S., Hernández‐Esquivel, L., Marín‐Hernández, Á., Hafidi, M. E., Gallardo‐Pérez, J. C., Hernández‐Reséndiz, I., Rodríguez‐Zavala, J. S., Pacheco-Velázquez, S. C., & Moreno‐Sánchez, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.010 · Cited by 72
Giordano, A., Calvani, M., Petillo, O., Grippo, P., Tuccillo, F. M., Melone, M. A. B., Bonelli, P., Calarco, A., & Peluso, G. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401636 · Cited by 68
Molecular Pathways: Tumor Cells Co-opt the Brain-Specific Metabolism Gene CPT1C to Promote Survival
Reilly, P. T., & Mak, T. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3281 · Cited by 68
Cirillo, A., Salle, A. D., Petillo, O., Melone, M. A. B., Grimaldi, G., Bellotti, A., Torelli, G., Santi, M. S. D., Cantatore, G., Marinelli, A., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28408 · Cited by 60
Shigemura, K., Sung, S., Kubo, H., Arnold, R. S., Fujisawa, M., Gotoh, A., Zhau, H. E., & Chung, L. W. K. (2007) · The Prostate · doi:10.1002/pros.20565 · Cited by 56
Carnitine palmitoyltransferase I in human carcinomas: A novel role in histone deacetylation?
Mazzarelli, P., Pucci, S., Bonanno, E., Sesti, F., Calvani, M., & Spagnoli, L. G. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.10.4742 · Cited by 56
Li, J., Zhao, S., Zhou, X., Zhang, T., Zhao, L., Miao, P., Song, S., Sun, X., Liu, J., Zhao, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074623 · Cited by 48
Liu, L., Wang, Y., Wu, J., Cui, J., & Chen, T. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-154 · Cited by 48
Gilardi, F., & Desvergne, B. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9050-5_5 · Cited by 45
Cabrero, À., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200294-jlr200 · Cited by 45
Lin, H., Lu, J.-P., Laflamme, P., Qiao, S.-J., Shayegan, B., Bryskin, I., Monardo, L., Wilson, B., Singh, G., & Pinthus, J. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000725 · Cited by 41
Carnitine palmitoyltransferase 1C deficiency causes motor impairment and hypoactivity
Carrasco, P., Jacas, J., Sahún, I., Muley, H., Ramírez, S., Puisac, B., Mezquita, P., Pié, J., Dierssen, M., & Casals, N. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.004 · Cited by 40
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
Roy, D., Mondal, S., Wang, C., He, X., Khurana, A., Giri, S., Hoffmann, R. G., Jung, D., Kim, S. H., Chini, E. N., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-13 · Cited by 40
Wakamiya, T., Suzuki, S. O., Hamasaki, H., Honda, H., Mizoguchi, M., Yoshimoto, K., & Iwaki, T. (2014) · Neuropathology · doi:10.1111/neup.12132 · Cited by 39
Tumor surveillance by circulating microRNAs: a hypothesis
Igaz, I., & Igaz, P. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1682-4 · Cited by 37
Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells
Kawashima, I., Mitsumori, T., Nozaki, Y., Yamamoto, T., Sueki, Y., Nakajima, K., & Kirito, K. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.03.005 · Cited by 37
Burdelski, C. M., Ruge, O. M., Melling, N., Koop, C., Simon, R., Steurer, S. A., Sauter, G., Kluth, M., Hube‐Magg, C., Minner, S. J. P., et al. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.03.024 · Cited by 37
JNK–NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress
Kostecka, A., Sznarkowska, A., Meller, K., Acedo, P., Shi, Y., Sakil, H. A. M., Kawiak, A., Lion, M., Królicka, A., Wilhelm, M., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.408 · Cited by 36
van der Leij, F. R., Kram, A. M., Bartelds, B., Roelofsen, H., Smid, G. B., Takens, J., Zammit, V. A., & Kuipers, J. R. G. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410777 · Cited by 36
The emerging world of microRNAs.
O’Driscoll, L. (2006) · PubMed · Cited by 35
Targeting leukemia’s “fatty tooth”
Samudio, I. J., & Konopleva, M. Y. (2015) · Blood · doi:10.1182/blood-2015-08-665125 · Cited by 27
Jothi, M., Nishijo, K., Keller, C., & Mal, A. K. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19346 · Cited by 26
de Souza, C. O., Kurauti, M. A., Silva, F. D. F., de Morais, H., Curi, R., Hirabara, S. M., Neto, J. C. R., & de Souza, H. M. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430326 · Cited by 20
Kim, M., Lim, D. Y., Kim, J., Chen, H., Lubet, R. A., Dong, Z., & Bode, A. M. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22232 · Cited by 17
Ishizawa, M., Kagechika, H., & Makishima, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.102 · Cited by 17
Li, J., Chanrion, M., Sawey, E. T., Wang, T., Chow, E. K., Tward, A. D., Su, Y., Xue, W., Lucito, R., Zender, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118480 · Cited by 14
Cited by
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Schlaepfer, I. R., & Joshi, M. (2020) · Endocrinology · doi:10.1210/endocr/bqz046 · Cited by 732
NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications
Ju, H.-Q., Lin, J.-F., Tian, T., Xie, D., & Xu, R.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00326-0 · Cited by 581
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
Fatty acid oxidation: An emerging facet of metabolic transformation in cancer
Ma, Y., Temkin, S. M., Hawkridge, A. M., Guo, C., Wang, W., Wang, X.-Y., & Fang, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.006 · Cited by 531
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
Metadata
- Authors
- Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F.
- Venue
- Cell Death & Disease
- Published
- 2016-05-19
- Volume
- 7
- Issue
- 5
- Pages
- e2226-e2226
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2399064224
- Cited by
- 545
- References
- 96
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.